Skip to main content
Erschienen in: Current Diabetes Reports 4/2014

01.04.2014 | Health Care Delivery Systems in Diabetes (D Wexler, Section Editor)

Rational Use of Electronic Health Records for Diabetes Population Management

verfasst von: Emma M. Eggleston, Michael Klompas

Erschienen in: Current Diabetes Reports | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Population management is increasingly invoked as an approach to improve the quality and value of diabetes care. Recent emphasis is driven by increased focus on both costs and measures of care as the US moves from fee for service to payment models in which providers are responsible for costs incurred, and outcomes achieved, for their entire patient population. The capacity of electronic health records (EHRs) to create patient registries, apply analytic tools, and facilitate provider- and patient-level interventions has allowed rapid evolution in the scope of population management initiatives. However, findings on the efficacy of these efforts for diabetes are mixed, and work remains to achieve the full potential of an-EHR based population approach. Here we seek to clarify definitions and key domains, provide an overview of evidence for EHR-based diabetes population management, and recommend future directions for applying the considerable power of EHRs to diabetes care and prevention.
Literatur
2.••
Zurück zum Zitat Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood). 2008;27:759–69. doi:10.1377/hlthaff.27.3.759. Exposition of the balance between individual care, population approach, and health care costs and need to address all 3 to improve quality and reduce costs.CrossRef Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood). 2008;27:759–69. doi:10.​1377/​hlthaff.​27.​3.​759. Exposition of the balance between individual care, population approach, and health care costs and need to address all 3 to improve quality and reduce costs.CrossRef
4.••
Zurück zum Zitat McCulloch DK, Price MJ, Hindmarsh M, et al. A population-based approach to diabetes management in a primary care setting: early results and lessons learned. Eff Clin Pract. 1998;1:12–22. This is an early, comprehensive and multifaceted approach to diabetes population management, with provider, patient, and team based care. Demonstrated impact on both process and outcome measures.PubMed McCulloch DK, Price MJ, Hindmarsh M, et al. A population-based approach to diabetes management in a primary care setting: early results and lessons learned. Eff Clin Pract. 1998;1:12–22. This is an early, comprehensive and multifaceted approach to diabetes population management, with provider, patient, and team based care. Demonstrated impact on both process and outcome measures.PubMed
5.
Zurück zum Zitat Montori VM, Dinneen SF, Gorman CA, et al. The impact of planned care and a diabetes electronic management system on community-based diabetes care: the Mayo Health System Diabetes Translation Project. Diabetes. 2002;25:1952–7. Montori VM, Dinneen SF, Gorman CA, et al. The impact of planned care and a diabetes electronic management system on community-based diabetes care: the Mayo Health System Diabetes Translation Project. Diabetes. 2002;25:1952–7.
6.
Zurück zum Zitat Grant RW, Hamrick HE, Sullivan CM, et al. Impact of population management with direct physician feedback on care of patients with type 2 diabetes. Diabetes. 2003;26:2275–80. Grant RW, Hamrick HE, Sullivan CM, et al. Impact of population management with direct physician feedback on care of patients with type 2 diabetes. Diabetes. 2003;26:2275–80.
7.
Zurück zum Zitat Meigs JB, Cagliero E, Dubey A, et al. A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes. 2003;26:750. Meigs JB, Cagliero E, Dubey A, et al. A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes. 2003;26:750.
8.••
9.
Zurück zum Zitat Cusack CM, Knudson AD, Kronstadt JL, Singer RF, Brown AL. Practice-based population health: information technology to support transformation to proactive primary care. Agency for Healthcare Research and Quality (AHRQ). 2010. doi: 10.0092. Cusack CM, Knudson AD, Kronstadt JL, Singer RF, Brown AL. Practice-based population health: information technology to support transformation to proactive primary care. Agency for Healthcare Research and Quality (AHRQ). 2010. doi: 10.​0092.
10.
Zurück zum Zitat Cassell C, Kanta J, Shah L. Population health management: leveraging data and analytics to achieve value. White Paper. CTG solutions. 2012. Cassell C, Kanta J, Shah L. Population health management: leveraging data and analytics to achieve value. White Paper. CTG solutions. 2012.
11.
Zurück zum Zitat Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes. 2009;32:287–94. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes. 2009;32:287–94.
12.•
Zurück zum Zitat American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes. 2013;36:1033–46. doi:10.2337/dc12-2625. Detailed analysis of the costs, both direct and indirect, of diabetes in the United States. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes. 2013;36:1033–46. doi:10.​2337/​dc12-2625. Detailed analysis of the costs, both direct and indirect, of diabetes in the United States.
14.
Zurück zum Zitat Pu J, Chewning B. Racial difference in diabetes preventive care. Res Soc Adm Pharm. 2013;6:790–6.CrossRef Pu J, Chewning B. Racial difference in diabetes preventive care. Res Soc Adm Pharm. 2013;6:790–6.CrossRef
15.
Zurück zum Zitat Nelson KM, Chapko MK, Reiber G, et al. The association between health insurance coverage and diabetes care; data from the 2000 Behavioral Risk Factor Surveillance System. Health Serv Res. 2005;40:361–72.PubMedCentralPubMedCrossRef Nelson KM, Chapko MK, Reiber G, et al. The association between health insurance coverage and diabetes care; data from the 2000 Behavioral Risk Factor Surveillance System. Health Serv Res. 2005;40:361–72.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Kirk JK, Bell RA, Bertoni AG, et al. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacother. 2005;39:1489–501.PubMedCrossRef Kirk JK, Bell RA, Bertoni AG, et al. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes. Ann Pharmacother. 2005;39:1489–501.PubMedCrossRef
17.
Zurück zum Zitat Racial disparities in diabetes mortality among persons aged 1-19 years—United States, 1979-2004. MMWR. 2007;56:1184–7. Racial disparities in diabetes mortality among persons aged 1-19 years—United States, 1979-2004. MMWR. 2007;56:1184–7.
18.
Zurück zum Zitat Trivedi AN, Grebla RC, Wright SM, Washington DL. Despite improved quality of care in the Veterans Affairs health system, racial disparity persists for important clinical outcomes. 2011;30:707–15. doi: 10.1377/hlthaff.2011.0074. Trivedi AN, Grebla RC, Wright SM, Washington DL. Despite improved quality of care in the Veterans Affairs health system, racial disparity persists for important clinical outcomes. 2011;30:707–15. doi: 10.​1377/​hlthaff.​2011.​0074.
19.
Zurück zum Zitat Donahoe SM, Stewart GC, Mccabe CH, et al. Diabetes and mortality following acute coronary syndromes. J Am Med Assoc. 2007;298:765–75.CrossRef Donahoe SM, Stewart GC, Mccabe CH, et al. Diabetes and mortality following acute coronary syndromes. J Am Med Assoc. 2007;298:765–75.CrossRef
20.
Zurück zum Zitat Gregg EW, Gu Q, Cheng YJ, et al. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med. 2007;147:149–55.PubMedCrossRef Gregg EW, Gu Q, Cheng YJ, et al. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med. 2007;147:149–55.PubMedCrossRef
21.
Zurück zum Zitat Harkness E, Macdonald W, Valderas J, et al. Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33:926–30.PubMedCentralPubMedCrossRef Harkness E, Macdonald W, Valderas J, et al. Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33:926–30.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Sinclair AJ, Conroy SP, Bayer AJ. Impact of diabetes on physical function in older people. Diabetes. 2008;31:233–5. Sinclair AJ, Conroy SP, Bayer AJ. Impact of diabetes on physical function in older people. Diabetes. 2008;31:233–5.
24.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.PubMedCrossRef Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.PubMedCrossRef
25.
Zurück zum Zitat Lindstrom J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673–9.PubMedCrossRef Lindstrom J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673–9.PubMedCrossRef
26.
Zurück zum Zitat Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371:1783–9. doi:10.1016/S0140-6736(08)60766-7.PubMedCrossRef Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371:1783–9. doi:10.​1016/​S0140-6736(08)60766-7.PubMedCrossRef
27.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352:837–53.CrossRef
28.
Zurück zum Zitat The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. doi: 10.1056/NEJM199309303291401. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. doi: 10.​1056/​NEJM199309303291​401.
29.
Zurück zum Zitat Kahn R, Robertson RM, Smith R, et al. The impact of prevention on reducing the burden of cardiovascular disease. Diabetes. 2008;31:1686–96. doi:10.2337/dc08-9022. Kahn R, Robertson RM, Smith R, et al. The impact of prevention on reducing the burden of cardiovascular disease. Diabetes. 2008;31:1686–96. doi:10.​2337/​dc08-9022.
30.
Zurück zum Zitat Saha S, Gerdtham UG, Johansson P. Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Pub Health. 2010;7:3150–65. doi:10.3390/ijerph7083150.CrossRef Saha S, Gerdtham UG, Johansson P. Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Pub Health. 2010;7:3150–65. doi:10.​3390/​ijerph7083150.CrossRef
31.
Zurück zum Zitat Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes. 2012;35:723–30. doi:10.2337/dc11-1468. Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes. 2012;35:723–30. doi:10.​2337/​dc11-1468.
32.••
Zurück zum Zitat Kaplan JB, Bennett T. Use of race and ethnicity in biomedical publication. J Am Med Assoc. 2003;289:2709–16. Framework and recommendations for systematic approach to use of race/ethnicity in the medical literature.CrossRef Kaplan JB, Bennett T. Use of race and ethnicity in biomedical publication. J Am Med Assoc. 2003;289:2709–16. Framework and recommendations for systematic approach to use of race/ethnicity in the medical literature.CrossRef
34.
Zurück zum Zitat Albu J, Sohler N, Matti-Orozco B, et al. Expansion of electronic health record-based screening, prevention, and management of diabetes in New York City. Prev Chron Dis. 2013;10:E13. doi:10.5888/pcd10.120148. Albu J, Sohler N, Matti-Orozco B, et al. Expansion of electronic health record-based screening, prevention, and management of diabetes in New York City. Prev Chron Dis. 2013;10:E13. doi:10.​5888/​pcd10.​120148.
35.
36.
Zurück zum Zitat Trajko B, Gabbay RA. Patient-centered medical home and diabetes. Diabetes Care. 2011;34:1047–53.CrossRef Trajko B, Gabbay RA. Patient-centered medical home and diabetes. Diabetes Care. 2011;34:1047–53.CrossRef
37.•
Zurück zum Zitat Bates DW, Bitton A. The future of health information technology in the patient-centered medical home. Health Aff (Millwood). 2010;29:614–21. doi:10.1377/hlthaff.2010.0007. Overview of the domains needed for effective implementation of patient centered medical home and assessment of progress in each domain.CrossRef Bates DW, Bitton A. The future of health information technology in the patient-centered medical home. Health Aff (Millwood). 2010;29:614–21. doi:10.​1377/​hlthaff.​2010.​0007. Overview of the domains needed for effective implementation of patient centered medical home and assessment of progress in each domain.CrossRef
38.
Zurück zum Zitat Buntin MB, Burke MF, Hoaglin MC, et al. The benefits of health information technology: a review of the recent literature shows predominantly positive results. Health Aff (Millwood). 2011;30:464–71. doi:10.1377/hlthaff.2011.0178.CrossRef Buntin MB, Burke MF, Hoaglin MC, et al. The benefits of health information technology: a review of the recent literature shows predominantly positive results. Health Aff (Millwood). 2011;30:464–71. doi:10.​1377/​hlthaff.​2011.​0178.CrossRef
39.••
Zurück zum Zitat Grant RW, Lester WT, Meigs JB, et al. New models of population management for patients with diabetes—using informatics tools to support primary care. Diabetes Res Clin Pract. 2006;74(S2):S220–4. Examples of 2 approaches to diabetes population management within conceptual framework for achieving effective population management.PubMedCrossRef Grant RW, Lester WT, Meigs JB, et al. New models of population management for patients with diabetes—using informatics tools to support primary care. Diabetes Res Clin Pract. 2006;74(S2):S220–4. Examples of 2 approaches to diabetes population management within conceptual framework for achieving effective population management.PubMedCrossRef
40.
Zurück zum Zitat Grant RW, Cagliero E, Sullivan CM, et al. A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes. 2004;27:2299–305. Grant RW, Cagliero E, Sullivan CM, et al. A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes. 2004;27:2299–305.
41.
Zurück zum Zitat Ciemins EL, Coon PJ, Fowles JB, et al. Beyond health information technology: critical factors necessary for effective diabetes management. J Diabetes Sci Technol. 2009;3:452–60.PubMedCentralPubMedCrossRef Ciemins EL, Coon PJ, Fowles JB, et al. Beyond health information technology: critical factors necessary for effective diabetes management. J Diabetes Sci Technol. 2009;3:452–60.PubMedCentralPubMedCrossRef
42.
Zurück zum Zitat Zai AH, Grant RW, Estey G, et al. Lessons from implementing a combined workflow-informatics system for diabetes management. J Am Med Inform Assoc. 2009;16:524–33.CrossRef Zai AH, Grant RW, Estey G, et al. Lessons from implementing a combined workflow-informatics system for diabetes management. J Am Med Inform Assoc. 2009;16:524–33.CrossRef
44.
Zurück zum Zitat Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R. Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Diabetes. 2013;36:914–21. doi:10.2337/dc12-0964. Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R. Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Diabetes. 2013;36:914–21. doi:10.​2337/​dc12-0964.
45.
Zurück zum Zitat Lawrence JM, Black MH, Zhang JL, Slezak JM, Takhar HS, Koebnick C, et al. Validation of pediatric diabetes care identification approaches for diagnosed cases by using information in the electronic health records of a large integrated managed health care organization. Am J Epidemiol. 2013. doi:10.1093/aje/kwt230. Lawrence JM, Black MH, Zhang JL, Slezak JM, Takhar HS, Koebnick C, et al. Validation of pediatric diabetes care identification approaches for diagnosed cases by using information in the electronic health records of a large integrated managed health care organization. Am J Epidemiol. 2013. doi:10.​1093/​aje/​kwt230.
46.
Zurück zum Zitat Kudyakov R, Bowen J, Ewen E, et al. Electronic health record use to classify patients with newly diagnosed vs preexisting type 2 diabetes: infrastructure for comparative effectiveness research and population health management. Popul Health Manag. 2012;15:3–11.PubMedCrossRef Kudyakov R, Bowen J, Ewen E, et al. Electronic health record use to classify patients with newly diagnosed vs preexisting type 2 diabetes: infrastructure for comparative effectiveness research and population health management. Popul Health Manag. 2012;15:3–11.PubMedCrossRef
47.
Zurück zum Zitat Makam AN, Nguyen OK, Moore B, et al. Identifying patients with diabetes and the earliest date of diagnosis in real time: an electronic health record case-finding algorithm. BMC Med Inform Decis Making. 2013;13:81. doi:10.1186/1472-6947-13-81.CrossRef Makam AN, Nguyen OK, Moore B, et al. Identifying patients with diabetes and the earliest date of diagnosis in real time: an electronic health record case-finding algorithm. BMC Med Inform Decis Making. 2013;13:81. doi:10.​1186/​1472-6947-13-81.CrossRef
48.
Zurück zum Zitat Saukkonen T, Cederberg H, Jokelainen J, Laakso M, Härkönen P, Keinänen-Kiukaanniemi S, et al. Limited overlap between intermediate hyperglycemia as defined by A1C 5.7–6.4 %, impaired fasting glucose, and impaired glucose tolerance. Diabetes Care. 2011;34:2314–6.PubMedCentralPubMedCrossRef Saukkonen T, Cederberg H, Jokelainen J, Laakso M, Härkönen P, Keinänen-Kiukaanniemi S, et al. Limited overlap between intermediate hyperglycemia as defined by A1C 5.7–6.4 %, impaired fasting glucose, and impaired glucose tolerance. Diabetes Care. 2011;34:2314–6.PubMedCentralPubMedCrossRef
49.
Zurück zum Zitat Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. Performance of A1C for the classification and prediction of diabetes. Diabetes Care. 2011;34:84–9.PubMedCentralPubMedCrossRef Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. Performance of A1C for the classification and prediction of diabetes. Diabetes Care. 2011;34:84–9.PubMedCentralPubMedCrossRef
50.
Zurück zum Zitat Christensen DL, Witte DR, Kaduka L, Jørgensen ME, Borch-Johnsen K, Mohan V, et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care. 2010;33:580–2. doi:10.2337/dc09-1843.PubMedCentralPubMedCrossRef Christensen DL, Witte DR, Kaduka L, Jørgensen ME, Borch-Johnsen K, Mohan V, et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care. 2010;33:580–2. doi:10.​2337/​dc09-1843.PubMedCentralPubMedCrossRef
51.
Zurück zum Zitat Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program. Diabetes Care. 2007;30:2453–7. doi:10.2337/dc06-2003.PubMedCentralPubMedCrossRef Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program. Diabetes Care. 2007;30:2453–7. doi:10.​2337/​dc06-2003.PubMedCentralPubMedCrossRef
52.
Zurück zum Zitat Herranz L, Saez-de-Ibarra L, Grande C, Pallardo LF. Non–glycemic-dependent reduction of late pregnancy A1C levels in women with type 1 diabetes. Diabetes Care. 2007;30:1579–80. doi:10.2337/dc06-2568.PubMedCrossRef Herranz L, Saez-de-Ibarra L, Grande C, Pallardo LF. Non–glycemic-dependent reduction of late pregnancy A1C levels in women with type 1 diabetes. Diabetes Care. 2007;30:1579–80. doi:10.​2337/​dc06-2568.PubMedCrossRef
54.
Zurück zum Zitat Sequist TD, Gandhi TK, Karson AS, et al. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease. J Am Med Inform Assoc. 2005;12:431–7.PubMedCentralPubMedCrossRef Sequist TD, Gandhi TK, Karson AS, et al. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease. J Am Med Inform Assoc. 2005;12:431–7.PubMedCentralPubMedCrossRef
56.
Zurück zum Zitat Holbrook A, Thabane L, Keshavjee K, et al. Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. Can Med Assoc J. 2009;181:37–44. doi:10.1503/cmaj.081272.CrossRef Holbrook A, Thabane L, Keshavjee K, et al. Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. Can Med Assoc J. 2009;181:37–44. doi:10.​1503/​cmaj.​081272.CrossRef
57.
Zurück zum Zitat Glasgow RE, Nutting PA, King DK, et al. Randomized effectiveness trial of a computer-assisted intervention to improve diabetes care. Diabetes. 2005;28:33–9. Glasgow RE, Nutting PA, King DK, et al. Randomized effectiveness trial of a computer-assisted intervention to improve diabetes care. Diabetes. 2005;28:33–9.
58.
Zurück zum Zitat Davidson MB, Ansari A, Karlan VJ. Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population. Diabetes. 2007;30:224–7. Davidson MB, Ansari A, Karlan VJ. Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population. Diabetes. 2007;30:224–7.
59.
Zurück zum Zitat Harris LT, Haneuse SJ, Martin DP, et al. Diabetes quality of care and outpatient utilization associated with electronic patient-provider messaging: a cross-sectional analysis. Diabetes. 2009;32:1182–7. Harris LT, Haneuse SJ, Martin DP, et al. Diabetes quality of care and outpatient utilization associated with electronic patient-provider messaging: a cross-sectional analysis. Diabetes. 2009;32:1182–7.
60.
Zurück zum Zitat King A, Wolfe G, Healy S, et al. Exploring methods to extend the reach of diabetes specialist expertise into primary care clinics. Diabetes Educ. 2006;32:525–30.PubMedCrossRef King A, Wolfe G, Healy S, et al. Exploring methods to extend the reach of diabetes specialist expertise into primary care clinics. Diabetes Educ. 2006;32:525–30.PubMedCrossRef
61.••
Zurück zum Zitat Ahmad FS, Tsang T. Diabetes prevention, health information technology, and meaningful use: challenges and opportunities. Am J Prev Med. 2013;44:S357–63. doi:10.1016/j.amepre.2012.12.020. This comprehensive overview of health IT use in diabetes prevention provides overview of meaningful use legislation, reviews studies on efficacy of EHR use in diabetes prevention, and delineates areas for future research.PubMedCrossRef Ahmad FS, Tsang T. Diabetes prevention, health information technology, and meaningful use: challenges and opportunities. Am J Prev Med. 2013;44:S357–63. doi:10.​1016/​j.​amepre.​2012.​12.​020. This comprehensive overview of health IT use in diabetes prevention provides overview of meaningful use legislation, reviews studies on efficacy of EHR use in diabetes prevention, and delineates areas for future research.PubMedCrossRef
62.
Zurück zum Zitat Balas EA, Krishna S, Kretschmer RA, et al. Computerized knowledge management in diabetes care. Med Care. 2004;42:610–21.PubMedCrossRef Balas EA, Krishna S, Kretschmer RA, et al. Computerized knowledge management in diabetes care. Med Care. 2004;42:610–21.PubMedCrossRef
64.••
Zurück zum Zitat Cleveringa FG, Gorter KJ, Van Den Donk M, et al. Computerized decision support systems in primary care for type 2 diabetes patients only improve patients outcomes when combined with feedback on performance and case management: a systematic review. Diabetes Technol Ther. 2013;15:180–92. doi:10.1089/dia.2012.0201. Up-to-date and thorough review of health IT based clinical decision support impact on diabetes care.PubMedCrossRef Cleveringa FG, Gorter KJ, Van Den Donk M, et al. Computerized decision support systems in primary care for type 2 diabetes patients only improve patients outcomes when combined with feedback on performance and case management: a systematic review. Diabetes Technol Ther. 2013;15:180–92. doi:10.​1089/​dia.​2012.​0201. Up-to-date and thorough review of health IT based clinical decision support impact on diabetes care.PubMedCrossRef
66.
Zurück zum Zitat Reed M, Huang J, Graetz I, et al. Outpatient electronic health records and the clinical care and outcomes of patients with diabetes mellitus. Ann Intern Med. 2012;157:482–9.PubMedCentralPubMedCrossRef Reed M, Huang J, Graetz I, et al. Outpatient electronic health records and the clinical care and outcomes of patients with diabetes mellitus. Ann Intern Med. 2012;157:482–9.PubMedCentralPubMedCrossRef
68.
Zurück zum Zitat Fan T, Koro CE, Fedder DO, et al. Ethnic disparities and trends in glycemic control among adults with type 2 diabetes in the U.S. from 1988 to 2002. Diabetes. 2006;29:1924–5. Fan T, Koro CE, Fedder DO, et al. Ethnic disparities and trends in glycemic control among adults with type 2 diabetes in the U.S. from 1988 to 2002. Diabetes. 2006;29:1924–5.
70.
Zurück zum Zitat Mayer-Davis EJ, Bell RA, Dabelea D, et al. The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study. Diabetes. 2009;32 Suppl 2:S99–S101. doi:10.2337/dc09-S201. Mayer-Davis EJ, Bell RA, Dabelea D, et al. The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study. Diabetes. 2009;32 Suppl 2:S99–S101. doi:10.​2337/​dc09-S201.
71.
Zurück zum Zitat Beckles GLA. Diabetes and Women’s Health Across the Life Stages: A Public Health Perspective. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Division of Diabetes translation. 2001. www.cdc.gov/diabetes/pubs/women. Beckles GLA. Diabetes and Women’s Health Across the Life Stages: A Public Health Perspective. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Division of Diabetes translation. 2001. www.​cdc.​gov/​diabetes/​pubs/​women.
72.
Zurück zum Zitat Wexler DJ, Grant RW, Meigs JB, et al. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes. 2005;28:514–20. Wexler DJ, Grant RW, Meigs JB, et al. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes. 2005;28:514–20.
73.
Zurück zum Zitat Robbins JM, Vaccarino V, Zhang H, et al. Socioeconomic status and type 2 diabetes in African American and non-Hispanic white women and men: evidence from the Third National Health and Nutrition Examination Survey. Am J Public Health. 2001;91:76–83.PubMedCentralPubMedCrossRef Robbins JM, Vaccarino V, Zhang H, et al. Socioeconomic status and type 2 diabetes in African American and non-Hispanic white women and men: evidence from the Third National Health and Nutrition Examination Survey. Am J Public Health. 2001;91:76–83.PubMedCentralPubMedCrossRef
74.
Zurück zum Zitat Seligman HK, Bindman AB, Vittinghoff E, et al. Food insecurity is associated with diabetes mellitus: results from the National Health Examination and Nutrition Examination Survey (NHANES) 1999-2002. J Gen Intern Med. 2007;22:1018–23.PubMedCentralPubMedCrossRef Seligman HK, Bindman AB, Vittinghoff E, et al. Food insecurity is associated with diabetes mellitus: results from the National Health Examination and Nutrition Examination Survey (NHANES) 1999-2002. J Gen Intern Med. 2007;22:1018–23.PubMedCentralPubMedCrossRef
75.
Zurück zum Zitat Ford ES, Mokdad AH, Giles WH, et al. Geographic variation in the prevalence of obesity, diabetes, and obesity-related behaviors. Obes Res. 2005;13:118–22.PubMedCrossRef Ford ES, Mokdad AH, Giles WH, et al. Geographic variation in the prevalence of obesity, diabetes, and obesity-related behaviors. Obes Res. 2005;13:118–22.PubMedCrossRef
76.
77.••
Zurück zum Zitat Baig AA, Wilkes AE, Davis AM, et al. The use of quality improvement and health information technology approaches to improve diabetes outcomes in African American and Hispanic patients. Med Care Res Rev. 2010;67:163S–97S. doi:10.1177/1077558710374621. Detailed review of HIT (health information technology) based interventions on diabetes process of care and intermediate diabetes outcomes in African American and Hispanic patients.PubMedCentralPubMedCrossRef Baig AA, Wilkes AE, Davis AM, et al. The use of quality improvement and health information technology approaches to improve diabetes outcomes in African American and Hispanic patients. Med Care Res Rev. 2010;67:163S–97S. doi:10.​1177/​1077558710374621​. Detailed review of HIT (health information technology) based interventions on diabetes process of care and intermediate diabetes outcomes in African American and Hispanic patients.PubMedCentralPubMedCrossRef
78.
Zurück zum Zitat Shields AE, Shin P, Leu MG, et al. Adoption of health information technology in community health centers: results of a national survey. Health Aff (Millwood). 2007;26:1373–83.CrossRef Shields AE, Shin P, Leu MG, et al. Adoption of health information technology in community health centers: results of a national survey. Health Aff (Millwood). 2007;26:1373–83.CrossRef
80.
Zurück zum Zitat Montori VM, Fernandez-Balsells M. Glycemic control in type 2 diabetes: time for an evidence-based about-face? Ann Intern Med. 2009;150:803–8.PubMedCrossRef Montori VM, Fernandez-Balsells M. Glycemic control in type 2 diabetes: time for an evidence-based about-face? Ann Intern Med. 2009;150:803–8.PubMedCrossRef
83.
Zurück zum Zitat Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. J Am Med Assoc. 2012;307:1583–4. doi:10.1001/jama.2012.500.CrossRef Selby JV, Beal AC, Frank L. The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. J Am Med Assoc. 2012;307:1583–4. doi:10.​1001/​jama.​2012.​500.CrossRef
84.
Zurück zum Zitat Cushman WC, Evans GW, Byington RP, Goff Jr DC, Grimm Jr RH, ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.PubMedCrossRef Cushman WC, Evans GW, Byington RP, Goff Jr DC, Grimm Jr RH, ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.PubMedCrossRef
85.
Zurück zum Zitat Duckworth W, Abraira C, Moritz T, Reda D, Emannele N, Reaven PD, et al. Intensive glucose control and complications in American veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39. doi:10.1056/NEJMoa0808431.PubMedCrossRef Duckworth W, Abraira C, Moritz T, Reda D, Emannele N, Reaven PD, et al. Intensive glucose control and complications in American veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39. doi:10.​1056/​NEJMoa0808431.PubMedCrossRef
87.
Zurück zum Zitat Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72. doi:10.1056/NEJMoa0802987.PubMedCrossRef Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72. doi:10.​1056/​NEJMoa0802987.PubMedCrossRef
90.
Zurück zum Zitat Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes. 2012;35:1364–79. doi:10.2337/dc12-0413. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes. 2012;35:1364–79. doi:10.​2337/​dc12-0413.
93.
Zurück zum Zitat Bitton A, Flier LA, Jha AK. Health information technology in the era of care delivery reform: to what end? J Am Med Assoc. 2012;307:2593–4.CrossRef Bitton A, Flier LA, Jha AK. Health information technology in the era of care delivery reform: to what end? J Am Med Assoc. 2012;307:2593–4.CrossRef
95.
Zurück zum Zitat Wolf L, Harvell J, Jha AK. Hospitals ineligible for federal meaningful-use incentives have dismally low rates of adoption of electronic health records. Health Aff (Millwood). 2012;31:505–13. doi:10.1377/hlthaff.2011.0351.CrossRef Wolf L, Harvell J, Jha AK. Hospitals ineligible for federal meaningful-use incentives have dismally low rates of adoption of electronic health records. Health Aff (Millwood). 2012;31:505–13. doi:10.​1377/​hlthaff.​2011.​0351.CrossRef
Metadaten
Titel
Rational Use of Electronic Health Records for Diabetes Population Management
verfasst von
Emma M. Eggleston
Michael Klompas
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 4/2014
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-014-0479-z

Weitere Artikel der Ausgabe 4/2014

Current Diabetes Reports 4/2014 Zur Ausgabe

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Behavioral Contributions to the Pathogenesis of Type 2 Diabetes

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Nutrigenetics: Bridging Two Worlds to Understand Type 2 Diabetes

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Does Disruption of Circadian Rhythms Contribute to Beta-Cell Failure in Type 2 Diabetes?

Pharmacologic Treatment of Type 2 Diabetes (A Vella, Section Editor)

Sulfonylureas: A New Look at Old Therapy

Pharmacologic Treatment of Type 2 Diabetes (A Vella, Section Editor)

Systematic Reviews to Ascertain the Safety of Diabetes Medications

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Alzheimer’s Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.